Heparin protects basic and acidic FGF from inactivation
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The ability of heparin or that of hexuronyl hexosaminoglygan sulfate (HHS‐4) to protect basic or acidic fibroblast growth factor (FGF) from acid or heat inactivation has been analyzed. Both freshly prepared basic and acidic FGF stimulate the growth of baby hamster kidney (BHK‐21) cells exposed to medium supplemented with transferrin and insulin. Freshly prepared basic FGF was 10 fold more potent than acidic FGF. The addition of heparin to the medium decreased the potency of basic FGF while it potentiated that of acidic FGF. Upon storage of FGF at −80°C, a decline in potency of both basic and acidic FGF was observed. Heparin, when added to the medium, potentiated their activities, which became similar to that of freshly prepared basic FGF. In order to test whether heparin could protect basic or acidic FGF from inactivation, both mitogens were exposed to acid conditions (1% trifluoroacetic acid, pH 1.08, 2 h) or heat (65°C, 5 min) which inactivate basic or acidic FGF. When exposed to such treatment in the presence of heparin or HHS‐4, basic and acidic FGF retained their potency. The effect of heparin and HHS‐4 on the bioactivity of basic and acidic FGF is truly of a protective nature, since they had no effect when added after inactivation of the mitogens. Potentiation of the bioactivity of the protected mitogens or of the inactivated one could only be observed when cells were exposed to high heparin or HHS‐4 concentrations. This indicates that heparin and HHS‐4, in addition to protecting FGF from inactivation, also acts at another locus, as yet unidentified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of FGF-2 to heparan sulfate also imparts stability to the growth factor.”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [40]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Markwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458
Epidermal Growth Factor and a New Derivative
Savage, C. R., & Cohen, S. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44568-7 · Cited by 1,208
Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., & Klagsbrun, M. (1984) · Science · doi:10.1126/science.6199844 · Cited by 933
Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial Cultivation
Thornton, S. C., Mueller, S. N., & Levine, E. M. (1983) · Science · doi:10.1126/science.6635659 · Cited by 793
Esch, F., Baird, A., Ling, N., Ueno, N., Hill, F., Denoroy, L., Klepper, R., Gospodarowicz, D., Böhlen, P., & Guillemin, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6507 · Cited by 693
Self-citationCultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth
Castellot, J., Addonizio, M., Rosenberg, R., & Karnovsky, M. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.90.2.372 · Cited by 679
Gospodarowicz, D., Cheng, J., Lui, G. M., Baird, A., & Böhlent, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6963 · Cited by 613
Self-citationPurification of a fibroblast growth factor from bovine pituitary.
Gospodarowicz, D. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41631-1 · Cited by 591
Self-citationPurification of the fibroblast growth factor activity from bovine brain.
Gospodarowicz, D., Bialecki, H., & Greenburg, G. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34863-9 · Cited by 492
Self-citation
Research works printed but not linked: 1
- Gospodarowicz D., 1986, Methods in Enzymology
Cited by
Items 501–600 of 902
Guillonneau, X., Tassin, J., Berrou, E., Bryckaert, M., Courtois, Y., & Mascarelli, F. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199601)166:1<170::aid-jcp19>3.0.co;2-j · Cited by 33
Kato, Y., Liu, K., Nakamura, T., & Sugiyama, Y. (1994) · Hepatology · doi:10.1002/hep.1840200223 · Cited by 33
Kiefer, P., Peters, G. G., & Dickson, C. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.12.5929-5936.1991 · Cited by 33
Bandara, G., Lin, C. W., Georgescu, H. I., Mendelow, D., & Evans, C. H. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90468-2 · Cited by 33
New Delivery Systems of Stem Cells for Vascular Regeneration in Ischemia
Fakoya, A. O. J. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00007 · Cited by 32
“Heparin stabilizes the growth factors preventing its degradation by ECM proteinases (76, 77).”
BackgroundPrincz, M. A., & Sheardown, H. D. (2008) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856208785540181 · Cited by 32
Mollmark, J. I., Park, A. J.-H., Kim, J. J., Wang, T. Z., Katzenell, S., Shipman, S. L., Zagorchev, L., Simons, M., & Mulligan‐Kehoe, M. J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.252544 · Cited by 32
Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma
Rasmuson, T., Grankvist, K., Jacobsen, J., & Ljungberg, B. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00290-8 · Cited by 32
“The stability of bFGF has been evaluated before [28,29], and during storage at 80 C a decline in the potency of bFGF was found.”
BackgroundEffect of Polyanions on the Structure and Stability of Repifermin™ (Keratinocyte Growth Factor-2)
Derrick, T., Grillo, A. O., Vitharana, S. N., Jones, L. S., Rexroad, J., Shah, A., Perkins, M. D., Spitznagel, T. M., & Middaugh, C. R. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20797 · Cited by 32
Factors inducing mast cell accumulation in skeletal muscle
Lefaucheur, J. P., Gjata, B., & Sébille, A. (1996) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1996.tb00901.x · Cited by 32
Proteoglycans and the acute-phase response in Alzheimer's disease brain
Leveugle, B., & Fillit, H. M. (1994) · Molecular Neurobiology · doi:10.1007/bf02816102 · Cited by 32
Rosengart, T. K., Kuperschmid, J. P., Maciag, T., & Clark, R. E. (1989) · Circulation Research · doi:10.1161/01.res.64.2.227 · Cited by 32
Heparan Sulfate Degradation in Tumor Cell Invasion and Angiogenesis
Vlodavsky, I., Eldor, A., Bar-Ner, M., Fridman, R., Cohen, I. R., & Klagsbrun, M. (1988) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-5037-6_22 · Cited by 32
Gannoun-Zaki, L., Pieri, I., Badet, J., Moenner, M., & Barritault, D. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90433-u · Cited by 32
Yoshikawa, T., Mizuno, A., Yasumuro, H., Inami, W., Vergara, M. N., Del Rio‐Tsonis, K., & Chiba, C. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00935.x · Cited by 31
Tissue Engineering of the Microvasculature
Tien, J. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180037 · Cited by 32
“Type I collagen protected FGF2 from tryptic digestion (253), and the ability of heparin to protect FGFs against denaturation is well-known (178).”
InfluentialGómez‐Pinilla, F., Miller, S., Choi, J., & Cotman, C. W. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00327-2 · Cited by 31
Glu-96 of Basic Fibroblast Growth Factor Is Essential for High Affinity Receptor Binding
Zhu, H., Ramnarayan, K., Anchin, J. M., Miao, W. Y., Sereno, A., Millman, L., Zheng, J., Balaji, V., & Wolff, M. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21869 · Cited by 31
“…Roghani et al., 1994; Pantoliano et al., 1994), increases the receptor affinity of bFGF (Roghani et al., 1994), protects bFGF from inactivation (Gospodarowicz and Cheng, 1986) and proteolytic degradation (Saksela et al., 1988; Sommer and Rifkin, 1989), and is essential for the mitogenic…”
BackgroundThe role of fibroblast growth factors and related oncogenes in tumor growth
Brem, H., & Klagsbrun, M. (1993) · Cancer treatment and research · doi:10.1007/978-1-4615-3088-6_10 · Cited by 31
Flgueiredo, B. C., Piccardo, P., Maysinger, D., Clarke, P. B. S., & Cuello, A. C. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90141-2 · Cited by 31
Tumova, S., & Bame, K. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9078 · Cited by 31
Nickle, A. C., Ko, S., & Merrill, A. E. (2023) · Differentiation · doi:10.1016/j.diff.2023.10.001 · Cited by 30
Heparin Augmentation Enhances Bioactive Properties of Acellular Extracellular Matrix Scaffold
Park, D. S. J., Mewhort, H. E., Teng, G., Belke, D. D., Turnbull, J., Svystonyuk, D. A., Guzzardi, D. G., Kang, S., & Fedak, P. W. M. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0004 · Cited by 30
Nakamura, S., Ishihara, M., Takikawa, M., Murakami, K., Kishimoto, S., Nakamura, S., Yanagibayashi, S., Mori, Y., Fujita, M., Kubo, S., et al. (2010) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31757 · Cited by 30
Seeger, A., & Rinas, U. (1996) · Journal of Chromatography A · doi:10.1016/0021-9673(96)00286-5 · Cited by 30
Colombier, M., Lafont, J. E., Blanquaert, F., Caruelle, J. P., Barritault, D., & Jl, S. (1999) · Cells Tissues Organs · doi:10.1159/000016651 · Cited by 30
“Thus, RGTAs mimic the properties of heparan sulfate proteoglycans towards HBGFs [Gospodarowicz and Cheng, 1986; Paralkar et al., 1990; McCaffrey et al., 1994].”
BackgroundEffect of low pH and heparin on the structure of acidic fibroblast growth factor
Pineda‐Lucena, A., de Castro, I. N., Lozano, R. M., Muñoz‐Willery, I., Zazo, M., & Giménez‐Gallego, G. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18881.x · Cited by 30
“It has been shown that low pH irreversibly inactivate FGF [12].”
BackgroundChleboun, J. O., & Martins, R. N. (1994) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1994.tb02179.x · Cited by 30
Ikegami, Y., Mizumachi, H., Yoshida, K., & Ijima, H. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.10.002 · Cited by 29
“In addition, heparin stabilizes growth factors by complexation [13,14], and thus is added to the culture medium as a growth factor-stabilizing agent.”
BackgroundLi, C., Nie, F., Liu, X., Chen, M., Chi, D., Li, S., Pipinos, I. I., & Li, X. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c11349 · Cited by 29
Expression of Basic Fibroblast Growth Factor in Nasal Polyps
Powers, M. R., Liebler, J. M., Qu, Z., Wall, M. A., Lagesse, P. C., & Rosenbaum, J. T. (1998) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348949810701014 · Cited by 29
Tucker, G. C., Boyer, B., Vallés, A. M., & Thiery, J. P. (1991) · Journal of Cell Science · doi:10.1242/jcs.100.2.371 · Cited by 29
Heparin-binding growth factor-I (endothelial cell growth factor) binds to endothelium in vivo
Rosengart, T. K., Kupferschmid, J. P., Ferrans, V. J., Casscells, W., Maciag, T., & Clark, R. E. (1988) · Journal of Vascular Surgery · doi:10.1016/0741-5214(88)90150-4 · Cited by 29
Furuya, Y., Sato, N., Akakura, K., Ichikawa, T., Suzuki, N., Sato, R., & Shimazaki, J. (1990) · PubMed · Cited by 29
Matrix proteoglycans in tumor inflammation and immunity
Deb, G., Cicala, A., Papadas, A., & Asimakopoulos, F. A. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00023.2022 · Cited by 28
Analytical approaches to uptake and release of hydrogel-associated FGF-2
Zieris, A., Prokoph, S., Welzel, P. B., Grimmer, M., Levental, K. R., Panyanuwat, W., Freudenberg, U., & Werner, C. (2009) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-009-3913-z · Cited by 28
“By binding to heparin, FGF-2 diffusion can be slowed down while simultaneously stabilizing the protein against loss of bioactivity [12, 13].”
BackgroundA Generic Strategy for Co‐Presentation of Heparin‐Binding Growth Factors Based on CVD Polymerization
Deng, X., & Lahann, J. (2012) · Macromolecular Rapid Communications · doi:10.1002/marc.201200343 · Cited by 29
Angiogenic growth factors potential new treatment for acute myocardial infarction?
Gonçalves, L. M. M. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00358-2 · Cited by 28
15N NMR Relaxation Studies of Free and Ligand-bound Human Acidic Fibroblast Growth Factor
Chi, Y., Kumar, T. K. S., Chiu, I., & Yu, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007205200 · Cited by 28
Effects of Endothelial Cell Growth Factor on Vascular Compromised Skin Flaps
Hom, D. B., & Assefa, G. (1992) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1992.01880060074016 · Cited by 28
Cross-talk among proteases and matrix in the control of growth factor action
Rifkin, D. B. (1997) · Fibrinolysis and Proteolysis · doi:10.1016/s0268-9499(97)80003-3 · Cited by 28
Tardieu, M., Slaoui, F., Josefonvicz, J., Courty, J., Gamby, C., & Barritault, D. (1989) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856289x00064 · Cited by 28
Riss, T., & Sirbasku, D. A. (1987) · PubMed · Cited by 28
FGF homologous factors are secreted from cells to induce FGFR ‐mediated anti‐apoptotic response
Biaduń, M., Sochacka, M., Karelus, R., Baran, K., Czyrek, A. A., Otlewski, J., Krowarsch, D., Opaliński, Ł., & Zakrzewska, M. (2023) · The FASEB Journal · doi:10.1096/fj.202300324r · Cited by 27
Kingma, S. D. K., Wagemans, T., IJlst, L., Bronckers, A. L. J. J., Kuppevelt, T. H. V., Everts, V. E., Wijburg, F. A., & van Vlies, N. (2016) · Bone · doi:10.1016/j.bone.2016.01.029 · Cited by 27
“This may lead to protection from inactivation, and increased distribution to target cells, as it has been shown that growth factors bound by GAGs are protected against inactivation [32].”
BackgroundAnabolic effect of aminoterminally truncated fibroblast growth factor 4 (FGF4) on bone
Kuroda, S., Kasugai, S., Oida, S., Iimura, T., Ohya, K., & Ohyama, T. (1999) · Bone · doi:10.1016/s8756-3282(99)00193-3 · Cited by 27
Princz, M. A., & Sheardown, H. D. (2012) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34128 · Cited by 27
Kiyota, S., Franzoni, L., Nicastro, G., Benedetti, A., Sérgio Oyama, Viviani, W., Gambarini, Â. G., Spisni, A., & de Miranda, M. T. M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020543e · Cited by 27
Moy, F. J., Seddon, A. P., Campbell, E., B�hlen, P., & Powers, R. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197806 · Cited by 27
“…been shown to protect FGF-2 from inactivation resulting from exposure to low pH, elevated temperature or proteases, and to restore bioactivity to inactive growth factor (Westall et al., 1983; Gospodarowicz and Cheng, 1986; Saksela et al., 1988; Sommer and Rifkin, 1989; Pineda-Lucena et al., 1994a).”
BackgroundDauchel, M. C., Courty, J., Méreau, A., & Barritault, D. (1989) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240390407 · Cited by 27
Fukunaga, K., Hijikata, S., Ishimura, K., Sonoda, R., Irie, T., & Uekama, K. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03771.x · Cited by 27
Amorim, S., Pires, R. A., da Costa, D. S., Reis, R. L., & Pashkuleva, I. (2013) · Langmuir · doi:10.1021/la400871c · Cited by 27
Kim, S. H., & Kiick, K. L. (2010) · Macromolecular Rapid Communications · doi:10.1002/marc.201000130 · Cited by 26
Heparan sulfate and cell division
Porcionatto, M. A., Nader, H. B., & Dietrich, C. P. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999000500006 · Cited by 27
“The results suggested that both heparin and heparan sulfate proteoglycan may protect FGF from inactivation and proteolysis (12,13) and function as a reservoir for the growth factor which would be released according to the proliferation needs of the cells (14).”
BackgroundMolecular and Developmental Biology Aspects of Fibroblast Growth Factor
Gospodarowicz, D. (1988) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-1980-2_3 · Cited by 26
Self-citationJones, E. M., & Baird, A. (1997) · Biochemical Journal · doi:10.1042/bj3230173 · Cited by 26
Matrix proteoglycans as effector molecules for epithelial cell function
Frevert, C., & Sannes, P. (2005) · European Respiratory Review · doi:10.1183/09059180.05.00009703 · Cited by 22
“Glycosaminoglycans have been shown to protect chemokines and growth factors from proteolysis [ 51 , 52].”
BackgroundQuaternized Chitosan/Heparin Polyelectrolyte Multilayer Films for Protein Delivery
Urbaniak, T., García‐Briones, G. S., Zhigunov, A., Hladysh, S., Adrian, E., Lobaz, V., Krunclová, T., Janoušková, O., Pop‐Georgievski, O., & Kubies, D. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00926 · Cited by 25
Hiraga, T., Tanaka, S., Ikegame, M., Koizumi, M., Iguchi, H., Nakajima, T., & Ozawa, H. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10131-9 · Cited by 25
An analysis of the effects of Alzheimer's plaques on living neurons
Carpenter, M. K., Crutcher, K. A., & Kater, S. B. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90002-s · Cited by 25
Fibroblast growth factors: Structure-activity on dopamine neurons in vitro
Mena, M. A., Casarejos, M. J., Giménez‐Gallego, G., & de Yébenes, J. G. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252959 · Cited by 25
In VivoBinding of Topically Applied Human bFGF on Rabbit Corneal Epithelial Wound
Assouline, M., Hutchinson, C., Morton, K., Mascarelli, F., Jeanny, J., Fayein, N. A., Pouliquen, Y. J. M., & Courtois, Y. (1989) · Growth Factors · doi:10.3109/08977198908998001 · Cited by 25
Moscatelli, D., & Devesly, P. (1990) · Growth Factors · doi:10.3109/08977199009037499 · Cited by 25
Ibukiyama, C. (1996) · Japanese Heart Journal · doi:10.1536/ihj.37.285 · Cited by 25
Collazos-Castro, J. E., García‐Rama, C., & Alves-Sampaio, A. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.02.023 · Cited by 24
Klein-Soyer, C., Beretz, A., Cazenave, J., Driot, F., & Maffrand, J. (1990) · Biology of the Cell · doi:10.1016/0248-4900(90)90313-r · Cited by 24
Paluck, S., & Maynard, H. (2017) · Polymer Chemistry · doi:10.1039/c7py00861a · Cited by 16
Heparin and Derivatives for Advanced Cell Therapies
Laner‐Plamberger, S., Oeller, M., Rohde, E., Schallmoser, K., & Strunk, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112041 · Cited by 24
“UFH further protected FGF from proteolytic cleavage [105] and basic or acidic inactivation [106] and increased the diffusion radius by influencing the binding of the growth factors to ECM proteoglycans [107].”
BackgroundKobayashi, F., Yamada, S., Taguwa, S., Kataoka, C., Naito, S., Hama, Y., Tani, H., Matsuura, Y., & Sugahara, K. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9388-z · Cited by 23
Longo, L. M., Lee, J., & Blaber, M. (2012) · Protein Science · doi:10.1002/pro.2175 · Cited by 23
Basic fibroblast growth factor is hepatotropic for rat liver in regeneration
Baruch, Y., Shoshany, G., Neufeld, G., & Enat, R. (1995) · Journal of Hepatology · doi:10.1016/s0168-8278(95)80012-3 · Cited by 23
Wu, J., Mao, Z., Hong, Y., Han, L., & Gao, C. (2013) · Bioconjugate Chemistry · doi:10.1021/bc300670t · Cited by 23
Secretion of ribonucleases by normal and immortalized cells grown in serum-free culture conditions
Moenner, M., Hatzi, E. G., & Badet, J. (1997) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-997-0098-y · Cited by 23
Interaction of Basic Fibroblast Growth Factor with Extracellular Matrix and Receptorsa
Moscatelli, D., Flaumenhaft, R. C., & Saksela, O. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb49028.x · Cited by 23
Shen, B., Wang, J., He, T., Chen, S., Wang, X., Chen, J., Shi, R., Wang, J., Wang, H., Huang, W., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.149017 · Cited by 22
Heparin and angiogenic therapy
Fujita, M. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1700 · Cited by 22
“growth factor to the extracellular matrix and creates a reservoir of the factor in a thermo-stable and proteaseresistant form([18,29,30]).”
Migration of cultured bovine trabecular meshwork cells to aqueous humor and constituents.
Hogg, P., Calthorpe, M., Ward, S., & Grierson, I. (1995) · PubMed · Cited by 22
Vascular Effects of Sustained-Release Fibroblast Growth Factors
Hom, D. B., Medhi, K., Juhn, S. K., Assefa, G., & Johnston, T. P. (1996) · Annals of Otology Rhinology & Laryngology · doi:10.1177/000348949610500205 · Cited by 22
Schmidt, A., Skaletz‐Rorowski, A., & Buddecke, E. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.479_b.x · Cited by 22
Promotion of gastrulation by maternal growth factor in cultured rabbit blastocysts
de Angelis, M. H., Gründker, C., Herrmann, B. G., Kispert, A., & Kirchner, C. (1995) · Cell and Tissue Research · doi:10.1007/bf00319141 · Cited by 22
Modulation of Neovascularization and Metastasis by Species of Heparin
Vlodavsky, I., Ishai-Michaeli, R., Mohsen, M., Bar‐Shavit, R., Catane, R., Ekre, H. P., & Svahn, C. M. (1992) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-2444-5_31 · Cited by 22
Cellular Responses Modulated by FGF-2 Adsorbed on Albumin/Heparin Layer-by-Layer Assemblies
Kumorek, M., Kubies, D., Filová, E., Houška, M., Kasoju, N., Chánová, E. M., Matějka, R., Krýslová, M., Bačáková, L., & Rypáček, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125484 · Cited by 21
“[5] Heparin interacts effectively with FGF-2 and participates in the complex formation between FGF-2 and the cell surface FGF receptor [6–8], protects FGF-2 from inactivation and maintains the potency of FGF-2 even in harsh conditions.[9] On the other hand, albumin is also commonly used as a protein carrier including…”
BackgroundZhong, Y., Zhang, L., Ding, A. G., Shenderova, A., Zhu, G., Pei, P., Chen, R. R., Mallery, S. R., Mooney, D. J., & Schwendeman, S. P. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.016 · Cited by 21
Martinez, G., Giacomo, C. D., Sorrenti, V., Carnazza, M. L., Ragusa, N., Barcellona, M. L., & Vanella, A. (2001) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20010115)63:2<136::aid-jnr1005>3.0.co;2-4 · Cited by 21
“…matrix acts as a storage site for FGF in vivo (Vlodavsky et al., 1987; Baird and Ling, 1987; Bashkin et al., 1989) and that the interaction of FGF with endothelial cell-derived heparan sulphate proteoglycan results in resistance of FGF to proteolytic degradation (Gospodarowicz and Cheng, 1986).”
BackgroundEndothelial cell growth factor and heparin regulate collagen gene expression in keloid fibroblasts
Tan, E. M. L., & Peltonen, J. T. K. (1991) · Biochemical Journal · doi:10.1042/bj2780863 · Cited by 21
Cavari, S., & Vannucchi, S. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81469-g · Cited by 21
Fan, S.-Q., Qin, L.-Y., Cai, J.-L., Zhu, G.-Y., Bin, X., & Yan, H.-S. (2007) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e318148c9d0 · Cited by 20
Chitosan/Pluronic Hydrogel Containing bFGF/Heparin for Encapsulation of Human Dermal Fibroblasts
Choi, J. S., & Yoo, H. S. (2012) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856212x630267 · Cited by 20
Preparation, structure and BMP-2 controlled release of heparin-conjugated hyaluronan microgels
Zhao, J., Luo, C., Chen, Y., Wu, D., Shen, C., Han, W., Tu, M., & Zeng, R. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.05.026 · Cited by 20
Improved recovery from limb ischaemia by delivery of an affinity-isolated heparan sulphate
Poon, S., Lu, X., Smith, R. A. A., Ho, P., Bhakoo, K. K., Nurcombe, V., & Cool, S. M. (2018) · Angiogenesis · doi:10.1007/s10456-018-9622-9 · Cited by 20
“Similar increased stability in FGF-2 (fibroblast growth factor-2) [26] and VEGF [19] has been observed in the presence of heparin, a highly sulphated form of HS [27]; however, due to its powerful anticoagulant activity [28], the administration of heparin raises strong concerns about associated bleeding [29], let alone…”
BackgroundOsteogenic activities of MC3T3-E1 cells on heparin-immobilized poly(caprolactone) membranes
Gümüşderelíoğlu, M., Karakeçili, A. G., & Demirtaş, T. T. (2011) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911511406329 · Cited by 20
“In addition, endothelial cell proliferation was increased in the presence of heparin-binding growth factors.(19,20) The number of attached fibroblasts increased on polylactic acid/chitosan surfaces in the presence of heparin.”
BackgroundIshibashi, H., Nakagawa, K., Nakashima, Y., & Sueishi, K. (1995) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00199343 · Cited by 20
“of bFGF by proteases [ 19 , 29] and develop a reservoir of biologically active bFGF in the extracellular matrix and on the cell surface.”
BackgroundHeparin is a promising agent for the treatment of endometriosis-associated fibrosis
Nasu, K., Tsuno, A., Hirao, M., Kobayashi, H., Yuge, A., & Narahara, H. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.02.057 · Cited by 20
Dabin, I., & Courtois, Y. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041470303 · Cited by 20
Belford, D. A., Hendry, I. A., & Parish, C. R. (1992) · Biochemistry · doi:10.1021/bi00143a020 · Cited by 20
Presta, M., Gualandris, A., Urbinati, C., Rusnati, M., Coltrini, D., Isacchi, A., Caccia, P., & Bergonzoni, L. (1993) · Growth Factors · doi:10.3109/08977199308991587 · Cited by 20
Hondermarck, H., Deudon, E., & Boilly, B. (1992) · Developmental Brain Research · doi:10.1016/0165-3806(92)90067-7 · Cited by 20
Structure‐Function Studies of Acidic Fibroblast Growth Factora
Burgess, W. H. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb49020.x · Cited by 20
Activities of Human Acidic Fibroblast Growth Factor in an In Vitro Dermal Equivalent Model
Dubertret, L., Brunner‐Ferber, F., Misiti, J., Thomas, K. A., & Dubertret, M.-L. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12486796 · Cited by 20
Detection and characterization of heparin-binding proteins with a gel overlay procedure
Mehlman, T., & Burgess, W. H. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90545-k · Cited by 20
Metadata
- Authors
- Gospodarowicz, D., & Cheng, J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Gospodarowicz, D.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 1986-09
- Volume
- 128
- Issue
- 3
- Pages
- 475-484
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W1972855766
- Cited by
- 853
- References
- 30
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 11 · 2021: 13 · 2020: 10 · 2019: 12 · 2018: 9 · 2017: 8 · 2016: 18 · 2015: 10 · 2014: 9 · 2013: 11 · 2012: 22
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cellular Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 20197)
- National Eye Institute (EY02186)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- heparin, basic fibroblast growth factor, acidic fibroblast growth factor, acid inactivation, thermal inactivation
- MeSH terms
- Animals, Cell Division, Cell Line, Fibroblast Growth Factors, Fibroblasts, Glycosaminoglycans, Cricetinae, Hot Temperature, Heparin, Hydrogen-Ion Concentration, Insulin, Kidney, Mesocricetus, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.